Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Dalia Elganainy, M.D.

Concepts (71)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cholangiocarcinoma220205340.560 Why?
Bile Duct Neoplasms220205880.560 Why?
Carcinoma, Pancreatic Ductal6202316960.500 Why?
Pancreatic Neoplasms5202353370.270 Why?
Image Processing, Computer-Assisted4202089710.170 Why?
Digestive System Neoplasms12019860.170 Why?
Pancreatic Ducts120183270.130 Why?
Nanostructures120205480.130 Why?
Models, Theoretical3202135860.120 Why?
Antimetabolites, Antineoplastic120176420.110 Why?
Antineoplastic Agents, Phytogenic120176210.110 Why?
Deoxycytidine120178390.110 Why?
Adenocarcinoma2202263870.110 Why?
Tomography, X-Ray Computed42020203460.110 Why?
Drug Carriers120177090.110 Why?
Tumor Burden3202119170.080 Why?
Immunotherapy2202145260.080 Why?
Nanoparticles1201719440.070 Why?
Survival Analysis12018102520.060 Why?
Multivariate Analysis12018122500.060 Why?
Neoplasms32021219760.050 Why?
Antibodies, Monoclonal1202093000.050 Why?
Claudins120231110.050 Why?
Drug Resistance, Neoplasm1201751990.050 Why?
Antineoplastic Combined Chemotherapy Protocols22022116260.050 Why?
Xenograft Model Antitumor Assays2202035720.050 Why?
Calibration120228200.040 Why?
Neoadjuvant Therapy2202227750.040 Why?
Treatment Outcome32021640170.040 Why?
Cell Line, Tumor32020167890.040 Why?
Area Under Curve1202116540.030 Why?
Aged, 80 and over22018583610.030 Why?
Drug Compounding120172470.030 Why?
Caveolin 1120172620.030 Why?
Humans1220237527410.030 Why?
Neoplasm Staging22018110910.030 Why?
Pancreatectomy120188190.030 Why?
ROC Curve1202135580.030 Why?
RNA1202327780.030 Why?
Middle Aged420202160540.030 Why?
Aged320201656290.030 Why?
Phantoms, Imaging1201924850.020 Why?
Immunologic Factors1202015720.020 Why?
Mice, Nude1201736680.020 Why?
Male520203543110.020 Why?
Linear Models1202159650.020 Why?
Adult320202166580.020 Why?
Tumor Microenvironment1202237000.020 Why?
DNA Mutational Analysis1201841790.020 Why?
Algorithms22019139840.020 Why?
Up-Regulation1201741940.020 Why?
Neoplasm Metastasis1201848810.020 Why?
Feasibility Studies1201851440.020 Why?
Gene Expression Regulation, Neoplastic1202384600.020 Why?
Biopsy1201867710.020 Why?
Combined Modality Therapy1201886600.020 Why?
Models, Statistical1202151070.020 Why?
Female320203850900.020 Why?
Databases, Factual1202178050.020 Why?
Phenotype12023164840.020 Why?
Immunohistochemistry12018113950.020 Why?
Longitudinal Studies12020142190.010 Why?
Prognosis12023292640.010 Why?
Cell Proliferation12017105080.010 Why?
Retrospective Studies22020787580.010 Why?
Apoptosis1201796570.010 Why?
Prospective Studies12022538630.010 Why?
Animals220201696000.010 Why?
Follow-Up Studies12018392230.010 Why?
Time Factors12017401950.010 Why?
Mice12020817660.010 Why?
Elganainy's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (71)
Co-Authors (17)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.